There’s still time to join us at the Kidney Bee Conference next month at Cincinnati Children's. This event is your opportunity to go beyond data and dive into how technologies like #Aquadex can be practically applied in your healthcare setting. cincyhearteducationseries.org/kb2025

Aquadex therapy is now adopted in 47 pediatric centers, including two recent additions in the Southeast. A meaningful step forward in supporting fluid management for critically ill children weighing 20 kg. or more. Read more: ir.nuwellis.com/news-releases/…

Lots of productive & collaborative sessions at the inaugural #KidneyBee2025 Summit in Cincinnati Great to learn how Aquadex is a tool helping pediatric care teams manage fluid overload for their patients. More practical topics, RRT discussions, & SIM content to come! #CACN

We’re excited to share that Nuwellis has signed an agreement with KDI Precision Manufacturing to support assembly of our Aquadex consoles and consumables - expanding our capabilities and a smooth handoff with people we know and trust. #Nuwellis

Diuretics failing? Aquadex supports outpatient fluid removal—less time in the ER, more time living. Connect with a rep today to learn more: [email protected] #Nuwellis #Ultrafiltration #diuretics #Aquadex #DiureticResistance #FluidControl

Fluid overload is common in AKI. Aquadex lets you act early—before conventional dialysis is needed. #KidneySupport #CriticalCare Learn more about inpatient and outpatient options with Aquadex here: nuwellis.com

Aquadex supports earlier fluid management that may reduce complications and shorten ICU stays. Better for patients and providers. Explore the clinical data behind this approach. See the evidence that supports early fluid management with Aquadex - buff.ly/vayqiwr

Every avoided admission is a win. Aquadex enables proactive outpatient care for fluid-overloaded heart failure and critical care patients—supporting better outcomes and lower costs. See how reimbursement adds up: buff.ly/X2CKhIu

Fluid overload can derail even the best-managed cardiac surgeries. Diuretics often fall short, increasing ICU stays and readmissions. Aquadex offers gentle, nurse-managed bedside fluid removal—before escalation. Curious? Reach out to our team! [email protected]

When diuretics aren’t enough, cardiac patients face increased ICU stays and renal risk. #Aquadex gently intervenes earlier for better outcomes. #CriticalCare #CardiacSurgery #FluidOverload #Nuwellis

Act before instability. Cardiac programs nationwide are adopting #Aquadex early to manage fluid imbalance proactively. #EarlyIntervention #CardiacRecovery buff.ly/zqZZhlo

Join us on Zoom with Ramesh Emani and Amin Yehya, MD, MS, FACC, FHFSA at 1pm EDT tomorrow, 8/26 to learn how to utilize #Aquadex therapy in hospital-based outpatient program. Register here to be part of the discussion! lnkd.in/ga93eySB

Nuwellis’ Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio bit.ly/46dRgxg $NUWE #FluidManagement #FluidOverload #Pediatric #CriticalCare #NIHGrant

Fluid matters in the ICU. When diuretics fall short, Aquadex delivers precise ultrafiltration with continuous monitoring and real control. Want to see the workflow in action? Message us and we will connect you with a Nuwellis clinical specialist. #Aquadex #ICU #FluidManagement

We’re excited to welcome #HFSA2025 to our home city, Minneapolis! Let’s connect Sept 26–29 to talk about the future of heart failure care. DM or email us to set up a meeting.

Nuwellis participated in a What This Means, where Ryan Marthaler, VP of Product Marketing & BD, discussed the ~$3M NIH grant to accelerate Vivian™, the pediatric CRRT device. Learn more: vimeo.com/1119231149/b46… Nuwellis $NUWE #FluidManagement #Ultrafiltration #NIHGrant

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment bit.ly/41WkfV8 $NUWE #CriticalCare #CardiacSurgery #FluidOverload #VirtualInvestor Virtual Investor Co.

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration bit.ly/4gDAgWg $NUWE #CriticalCare #CardiacSurgery #FluidOverload

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex® bit.ly/4n1cgxX $NUWE #CriticalCare #CardiacSurgery #FluidOverload